Researchers ID Signature for Predicting Lymphoma Treatment Success | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A gene expression signature associated with activation of the tumor necrosis factor CD40 pathway can help predict response to a new B cell cancer treatment targeting the pathway, according to an online study in Science Translational Medicine today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.